A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Phase of Trial: Phase III
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Cannabidiol
- Indications Infantile spasms
- Focus Adverse reactions
- Sponsors GW Pharmaceuticals
- 20 Oct 2017 Planned End Date changed from 1 Jan 2020 to 1 Dec 2018.
- 20 Oct 2017 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2018.
- 17 Mar 2017 Status changed from active, no longer recruiting to recruiting.